1-1 of 1
Keywords: combination markers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization

Jing-Xuan Xu, Shui-Lin Qin, Hao-Wen Wei, Yuan-Yuan Chen, Yu-Chong Peng, Lu-Nan Qi
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (4): 303–316.
DOI: https://doi.org/10.1042/CS20220661
Published: 17 February 2023
... models. Conclusion: Down-regulation of ALDOB may underlie the metabolic reprogramming observed in HCC by promoting the malignant behavior of HCC cells. Hypoxia and ALDOB down-regulation acted additively, which was closely related to PA-TACE insensitivity. The use of ALDOB and Ki67 as a combined marker...
View article titled, Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization
Open the PDF for Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization in another window
Includes: Supplementary data